Atropos Health

New York, NY · Founded 2020 · Privately Held (backing)

Developer of a clinical analytics platform designed to transform health data into usable real-world evidence. Atropos Health is based in New York, NY and was founded in 2020. It has raised $55 million across 3 recorded rounds; the latest was a $33 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$55.0M
Last round
Early Stage VC
May 2024

Atropos Health key facts

  • Developer of a clinical analytics platform designed to transform health data into usable real-world evidence.
  • It has raised $55.0M across 3 recorded rounds; the latest was Early Stage VC ($33.0M) in May 2024.
  • Notable investors include Mana Ventures, Gaingels, Samsung NEXT Ventures, Breyer Capital, Emerson Collective — 19 tracked in total.
  • Atropos Health has filed 3 Form Ds with the SEC since 2022, most recently May 2024 ($33.0M sold to 7 investors).
  • Status: Privately Held (backing).

Atropos Health leadership

Free account
More of Atropos Health with a free account
  • ·The complete investor list: 19 names
  • ·Everyone on the team, board and advisors included
  • ·Watch Atropos Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Atropos Health funding rounds

3 rounds
May 2024Early Stage VC$33.0MSEC filing▮
Jul 2023Seed Round$3.3MSEC filing▮
Aug 2022Early Stage VC$8.0MSEC filing▮

How much has Atropos Health raised?

Atropos Health has raised $55 million across 3 recorded rounds since 2022. The largest was an $8 million early-stage round in Aug 2022; the most recent was a $33 million early-stage round in May 2024.

Atropos Health has filed 3 Form Ds with the SEC since 2022, most recently in May 2024 ($33 million sold to 7 investors).

Atropos Health investors

19 investors are on record for Atropos Health, including Mana Ventures, Gaingels, Samsung NEXT Ventures and Breyer Capital. By type, the record holds 6 venture capital firms and 1 asset manager. The early-stage round in May 2024 drew 7 investors.

Who runs Atropos Health

15 people are listed on the Atropos Health team: 8 executives and 7 board members, including Saurabh Gombar (Chief Medical Officer) and Andrew Turitz (Chief Financial Officer). 15 of them have a verified direct contact on file.

About Atropos Health

Developer of a clinical analytics platform designed to transform health data into usable real-world evidence. The company's platform leverages electronic medical record data to derive digital evidence for individual patient outcomes with data-driven care, and expedites research that advances the field of medicine, enabling healthcare institutions to create value from previously siloed EMR data.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2020
Employees
37
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation — not yet priced

Atropos Health doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.